Listen Now
Topics Covered
- Overview of Blood Cancers, in the Context of COVID-19
- New Research Presented at ASH
- Disease-Specific Treatment Updates from ASH on:
- Lymphoma
- Multiple Myeloma
- Leukemia
- Myeloproliferative Disorders
- The Role of Precision Medicine & Clinical Trials
- The Increasing Role of Telemedicine/Telehealth Appointments
- Guidelines to Prepare for These Appointments to Increase Their Benefits, including Technology, List of Questions & Discussion of OpenNotes
- Key Questions to Ask Your Healthcare Team about Quality-of-Life Concerns & Goal of Care
- Questions for Our Panel of Experts
Our Panel of Experts

Peter Martin, MD, MS
Chief, Lymphoma Program, Associate Professor of Medicine, Weill Cornell Medicine, Associate Attending Physician, NewYork-Presbyterian Hospital

Matthew J. Butler, MD
Assistant Professor of Medicine, Division of Hematology/Oncology, Department of Medicine, Mays MD Anderson Cancer Center, UT Health San Antonio

Michael J. Mauro, MD
Leader, Myeloproliferative Neoplasms Program, Member, Memorial Sloan Kettering Cancer Center, Professor, Weill Cornell Medicine

Ruben A. Mesa, MD, FACP
Executive Director, Mays Cancer Center at UT Health San Antonio MD Anderson, Mays Family Foundation Distinguished University Presidential Chair, Professor of Medicine, Mays Cancer Center – An NCI Designated Cancer Center

Carolyn Messner, DSW, BCD, FAPOS, FAOSW
Director of Education and Training, CancerCare
Brochure
You can download the brochure for this workshop
Workshop Date
This workshop was originally recorded on December 16, 2021.